NRT Smoking Cessation Aids in Brazil

October 2019 | 3 pages | ID: N420B8A1512EN
Euromonitor International Ltd

Abstracts

Euromonitor?s data on tobacco in Brazil point to sales posting a positive trajectory over the last few years. The positive prospects for this industry may also be seen as a positive factor driving sales of NRT smoking cessation aids in the country, as the latter category depends on smokers to continue selling its products. On average, smoking prevalence among the adult Brazilian population is 12% in 2018, resulting in more than 18 million people smoking.

Euromonitor International's NRT Smoking Cessation Aids in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: OTC.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the NRT Smoking Cessation Aids market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

HEADLINES
PROSPECTS
Positive prospects for tobacco sales should favour NRT smoking cessation aids
COMPETITIVE LANDSCAPE
Johnson & Johnson and Perrigo dominate sales in Brazil
CATEGORY INDICATORS
Table 1 Number of Smokers by Gender 2014-2019
CATEGORY DATA
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2014-2019
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2014-2019
Table 4 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2015-2019
Table 5 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2016-2019
Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
EXECUTIVE SUMMARY
Consumer health sales continue to grow strongly in 2019
Positive performance despite the lack of innovation
Leading companies reinforce their position, but competition affects the competitive landscape
Parapharmacies/Drugstores continues to dominate sales, but internet retailing grows stronger
Future growth to remain positive
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 9 Life Expectancy at Birth 2014-2019
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2014-2019
Table 11 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 12 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 13 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine
Switches
DEFINITIONS
SOURCES
Summary 1 Research Sources